You are invited to attend a clinical presentation about the efficacy and safety of Venclexta regimens in the treatment of CLL: “Exploring Time Off Treatment with a BCL-2 Inhibitor”
Speaker:
Nadia Khan MD
Swedish Cancer Institute, SCI Center for Blood Disorders and Cellular Therapy
To RSVP:
Respond with the QR code on the flier (attached)
or
Jules Holland
(253) 349-3350
or
RSVP online: https://abbviespeakerprograms.